Skip to content
← Full study record

NCT00635024 · MORE INFO

Limitations, agreements, and source contact

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma · Source last updated 2017-02-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
After 1 patient was recruited, this trial temporarily closed to allow the first dose of Anti-thymocyte Globulin to be split over two days. Before the modification was written, it was decided to permanently close this study due to competing trials.
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic
title
Dr. Shaji Kumar
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
limitations And Caveats
description
After 1 patient was recruited, this trial temporarily closed to allow the first dose of Anti-thymocyte Globulin to be split over two days. Before the modification was written, it was decided to permanently close this study due to competing trials.
point Of Contact
email
kumar.shaji@mayo.edu
organization
Mayo Clinic
title
Dr. Shaji Kumar

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice